Dr. Simon Laurence Conti, MD

Dr. Conti practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Conti's NPI, 1679708705, was assigned on May 19, 2009. Dr. Conti graduated from UCSF School of Medicine in 2009. Dr. Conti holds California license A113515.

Dr. Conti's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Conti's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Conti is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Conti to 1 more hospital and 1 medical group, each named with a free account. Dr. Conti's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Conti practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Conti's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Conti is board certified in urology by the American Board of Urology. Dr. Conti is licensed in California.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney disease, kidney removal surgery, kidney stone disease and kidney stones among the conditions Dr. Conti treats.

CMS data shows 400 Medicare services from Dr. Conti across 8 procedure codes in 2024, for 287 Medicare patients. Medicare paid $54,270 for them.

CMS counts 287 Medicare patients who saw Dr. Conti in 2024. The largest group is 65 to 74, with 134 patients. 70% of them have high cholesterol, and 67% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Conti's median patient age at 61, with 46% women.

In 2024, Dr. Conti wrote 330 Medicare Part D claims for 104 patients. 96% of them were for generic drugs. CMS names the drug for 262 of them, across 7 drugs with 11 or more claims each, at $6,882 in total drug cost. In 2023, CMS named 282 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Conti for performance year 2024, reported as part of a group. Dr. Conti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Conti as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 53 papers to Dr. Conti, published from 2007 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Urinary Calculi, Kidney Calculi and Ureteroscopy. Dr. Conti has published most often in J Endourol. Dr. Conti's most frequent co-authors are John Thomas Leppert, MD, Alan Chun-Yao Pao, MD and Christopher S. Elliott, MD.

CMS Open Payments shows 17 general payments to Dr. Conti from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Ethicon Inc. paid the most, $12,836.

Dr. Conti graduated from UCSF School of Medicine in 2009.

Dr. Conti is in network with 10 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.